Form 13-F position report

BIOMARIN PHARMACEUTICAL INC

Reported by MIZUHO SECURITIES USA LLC

BMRN 1.5 10/15/20 CUSIP 09061GAF8 Manager CIK 0001513006

Reported 0 shares, down 5,900,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2019
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q4 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for BIOMARIN PHARMACEUTICAL INC held by MIZUHO SECURITIES USA LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

52 managers reported BIOMARIN PHARMACEUTICAL INC for Q4 2019.

Managers reporting BIOMARIN PHARMACEUTICAL INC in Q4 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Allianz Asset Management GmbH Unchanged 52,955,000 0 0.05% $57,631,000 19 qtrs
Calamos Advisors LLC Reduced 49,022 -503 0.26% $53,288,000 25 qtrs
Invesco Ltd Unchanged 42,266,000 0 0.01% $45,914,000 25 qtrs
ROYAL BANK OF CANADA Added 38,875,000 +6,211,000 0.02% $42,177,000 25 qtrs
ADVENT CAPITAL MANAGEMENT DE Reduced 37,781,000 -162,000 0.79% $41,037,000 25 qtrs
Polar Capital LLP New 37,223,000 +37,223,000 0.35% $40,529,000 1 qtr
FRANKLIN RESOURCES INC Unchanged 29,700,000 0 0.02% $32,338,000 25 qtrs
NOMURA HOLDINGS INC Reduced 28,500,000 -8,500,000 0.09% $24,085,000 6 qtrs
PFM Health Sciences LP New 18,275,000 +18,275,000 0.95% $19,842,000 1 qtr
STATE STREET CORPORATION Added 12,300,000 +300,000 < 0.01% $13,383,000 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2019
Filed
January 30, 2020
Filing type
13F-HR
Position type
NOTE 1.500%10/1

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.